MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 71 filers reported holding MERSANA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $458,089 | -75.9% | 360,700 | -37.6% | 0.00% | -80.0% |
| Q2 2023 | $1,901,949 | -42.5% | 578,100 | -28.1% | 0.01% | -44.4% |
| Q1 2023 | $3,306,495 | -46.4% | 804,500 | -23.6% | 0.01% | -47.1% |
| Q4 2022 | $6,172,338 | -18.3% | 1,053,300 | -5.8% | 0.02% | -22.7% |
| Q3 2022 | $7,556,000 | +50.5% | 1,117,700 | +2.9% | 0.02% | +57.1% |
| Q2 2022 | $5,021,000 | -6.8% | 1,086,700 | -19.5% | 0.01% | 0.0% |
| Q1 2022 | $5,385,000 | -17.6% | 1,349,500 | +28.5% | 0.01% | -12.5% |
| Q4 2021 | $6,532,000 | +9.9% | 1,050,200 | +66.7% | 0.02% | +6.7% |
| Q3 2021 | $5,941,000 | -22.9% | 630,000 | +11.0% | 0.02% | -25.0% |
| Q2 2021 | $7,708,000 | -18.8% | 567,600 | -3.3% | 0.02% | -23.1% |
| Q1 2021 | $9,493,000 | -27.2% | 586,700 | +19.8% | 0.03% | -25.7% |
| Q4 2020 | $13,036,000 | +137.7% | 489,900 | +66.3% | 0.04% | +118.8% |
| Q3 2020 | $5,484,000 | +92.8% | 294,500 | +142.2% | 0.02% | +100.0% |
| Q2 2020 | $2,845,000 | +848.3% | 121,600 | +136.1% | 0.01% | +700.0% |
| Q1 2020 | $300,000 | +40.2% | 51,500 | +37.7% | 0.00% | – |
| Q4 2019 | $214,000 | +275.4% | 37,400 | +4.2% | 0.00% | – |
| Q3 2019 | $57,000 | +21.3% | 35,900 | +212.2% | 0.00% | – |
| Q2 2019 | $47,000 | – | 11,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 796,458 | $14,830,000 | 12.35% |
| Consonance Capital Management LP | 3,468,171 | $64,577,000 | 7.87% |
| Sarissa Capital Management LP | 2,837,000 | $52,824,000 | 6.22% |
| Bain Capital Life Sciences Investors, LLC | 3,445,667 | $64,158,000 | 5.98% |
| Ghost Tree Capital, LLC | 1,050,000 | $19,551,000 | 5.65% |
| NEA Management Company, LLC | 5,959,520 | $110,966,000 | 4.70% |
| Soleus Capital Management, L.P. | 393,041 | $7,318,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 667,500 | $12,429,000 | 3.38% |
| Avoro Capital Advisors LLC | 6,800,000 | $126,616,000 | 1.80% |
| FNY Investment Advisers, LLC | 199,800 | $3,720,000 | 1.57% |